Birmingham Children’s Hospital - Articles and news items

UK regulatory support for Vtesse’s Niemann-Pick drug for children

Industry news / 4 November 2016 / Niamh Louise Marriott, Digital Content Producer

The MHRA has granted a Promising Innovative Medicine designation for VTS-270, Vtesse’s investigational drug for children with Niemann-Pick Type C1 disease…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+